Advertisement
ABT vs SYK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and SYK is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABT’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 2 green FA rating(s).
- ABT’s FA Score: 1 green, 4 red.
- SYK’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABT’s TA Score shows that 2 TA indicator(s) are bullish while SYK’s TA Score has 5 bullish TA indicator(s).
- ABT’s TA Score: 2 bullish, 6 bearish.
- SYK’s TA Score: 5 bullish, 4 bearish.
Price Growth
ABT (@Medical/Nursing Services) experienced а -3.84% price change this week, while SYK (@Medical/Nursing Services) price change was -0.26% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.03%. For the same industry, the average monthly price growth was +3.31%, and the average quarterly price growth was +18.95%.
Reported Earning Dates
ABT is expected to report earnings on Jan 28, 2026.
SYK is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Medical/Nursing Services (+1.03% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ABT | SYK | ABT / SYK | |
| Capitalization | 222B | 141B | 157% |
| EBITDA | 11.6B | 5.76B | 201% |
| Gain YTD | 14.975 | 3.246 | 461% |
| P/E Ratio | 16.01 | 48.91 | 33% |
| Revenue | 43.1B | 23.8B | 181% |
| Total Cash | N/A | N/A | - |
| Total Debt | 13.4B | 16.6B | 81% |
ABT | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 56 | 21 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 53 | 58 | |
P/E GROWTH RATING 1..100 | 96 | 23 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABT's Valuation (16) in the Medical Specialties industry is somewhat better than the same rating for SYK (61). This means that ABT’s stock grew somewhat faster than SYK’s over the last 12 months.
SYK's Profit vs Risk Rating (21) in the Medical Specialties industry is somewhat better than the same rating for ABT (56). This means that SYK’s stock grew somewhat faster than ABT’s over the last 12 months.
SYK's SMR Rating (100) in the Medical Specialties industry is in the same range as ABT (100). This means that SYK’s stock grew similarly to ABT’s over the last 12 months.
ABT's Price Growth Rating (53) in the Medical Specialties industry is in the same range as SYK (58). This means that ABT’s stock grew similarly to SYK’s over the last 12 months.
SYK's P/E Growth Rating (23) in the Medical Specialties industry is significantly better than the same rating for ABT (96). This means that SYK’s stock grew significantly faster than ABT’s over the last 12 months.
| ABT | SYK | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 80% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 42% | 2 days ago 55% |
| MACD ODDS (%) | 2 days ago 47% | 2 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 50% | 2 days ago 51% |
| TrendMonth ODDS (%) | 2 days ago 48% | 2 days ago 46% |
| Advances ODDS (%) | 26 days ago 56% | 4 days ago 54% |
| Declines ODDS (%) | 2 days ago 50% | 2 days ago 52% |
| BollingerBands ODDS (%) | 2 days ago 56% | 4 days ago 68% |
| Aroon ODDS (%) | N/A | 2 days ago 42% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QEMM | 67.28 | 0.61 | +0.91% |
| SPDR® MSCI Emerging Mkts StratcFacts ETF | |||
| QQQY | 24.90 | 0.02 | +0.09% |
| Defiance Nasdaq 100 Target 30 Income ETF | |||
| VOT | 289.14 | -3.37 | -1.15% |
| Vanguard Mid-Cap Growth ETF | |||
| RDIV | 51.07 | -0.61 | -1.18% |
| Invesco S&P Ultra Dividend Revenue ETF | |||
| RSPA | 50.40 | -0.72 | -1.41% |
| Invesco S&P 500 Eq Wght Inc Adv ETF | |||
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with BSX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then BSX could also see price increases.